WATCH NOW: Top-5 Stocks in India's $10 Trillion Rally
Here is the latest financial fact sheet of MOREPEN LABS. For more details, see the MOREPEN LABS quarterly results and MOREPEN LABS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.1 |
No. of shares | m | 511.17 |
1 Week | % | -3.5 |
1 Month | % | 10.0 |
1 Year | % | 75.7 |
52 week H/L | Rs | 56.4/25.3 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
MOREPEN LABS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 41 | 24 | 39 | 75 | 55 | |
Low | Rs | 15 | 7 | 9 | 32 | 24 | |
Sales per share (Unadj.) | Rs | 17.1 | 19.0 | 26.4 | 32.4 | 27.7 | |
Earnings per share (Unadj.) | Rs | 0.6 | 0.7 | 2.2 | 2.1 | 0.8 | |
Diluted earnings per share | Rs | 0.6 | 0.7 | 1.9 | 2.0 | 0.8 | |
Cash flow per share (Unadj.) | Rs | 1.5 | 1.6 | 2.8 | 2.7 | 1.3 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 5.6 | 6.3 | 8.5 | 11.6 | 14.7 | |
Adj. book value per share | Rs | 5.0 | 5.6 | 7.5 | 10.8 | 14.7 | |
Shares outstanding (eoy) | m | 449.83 | 449.83 | 449.83 | 477.83 | 511.17 | |
Price / Sales ratio | x | 1.6 | 0.8 | 0.9 | 1.7 | 1.4 | |
Avg P/E ratio | x | 43.7 | 20.9 | 11.1 | 25.1 | 51.8 | |
P/CF ratio (eoy) | x | 18.3 | 10.0 | 8.5 | 19.7 | 30.1 | |
Price / Book Value ratio | x | 5.0 | 2.5 | 2.8 | 4.6 | 2.7 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 12,595 | 7,020 | 10,809 | 25,540 | 20,051 | |
Total wages/salary | Rs m | 954 | 1,099 | 1,356 | 1,642 | 1,547 |
MOREPEN LABS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 7,685 | 8,531 | 11,881 | 15,468 | 14,175 | |
Other income | Rs m | 37 | 95 | 121 | 201 | 61 | |
Total revenues | Rs m | 7,722 | 8,626 | 12,001 | 15,669 | 14,237 | |
Gross profit | Rs m | 675 | 685 | 1,185 | 1,367 | 795 | |
Depreciation | Rs m | 399 | 369 | 303 | 276 | 279 | |
Interest | Rs m | 21 | 20 | 18 | 24 | 20 | |
Profit before tax | Rs m | 292 | 391 | 985 | 1,267 | 558 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 3 | 55 | 14 | 250 | 171 | |
Profit after tax | Rs m | 288 | 336 | 971 | 1,017 | 387 | |
Gross profit margin | % | 8.8 | 8.0 | 10.0 | 8.8 | 5.6 | |
Effective tax rate | % | 1.2 | 14.1 | 1.4 | 19.7 | 30.6 | |
Net profit margin | % | 3.8 | 3.9 | 8.2 | 6.6 | 2.7 |
MOREPEN LABS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,995 | 3,722 | 5,268 | 7,343 | 7,562 | |
Current liabilities | Rs m | 3,392 | 3,514 | 4,038 | 4,565 | 3,212 | |
Net working cap to sales | % | -5.2 | 2.4 | 10.4 | 18.0 | 30.7 | |
Current ratio | x | 0.9 | 1.1 | 1.3 | 1.6 | 2.4 | |
Inventory Days | Days | 38 | 32 | 32 | 16 | 18 | |
Debtors Days | Days | 635 | 589 | 559 | 591 | 678 | |
Net fixed assets | Rs m | 3,157 | 2,913 | 3,314 | 3,358 | 3,543 | |
Share capital | Rs m | 900 | 900 | 900 | 956 | 1,022 | |
"Free" reserves | Rs m | 1,631 | 1,941 | 2,910 | 4,568 | 6,507 | |
Net worth | Rs m | 2,531 | 2,841 | 3,810 | 5,523 | 7,529 | |
Long term debt | Rs m | 18 | 9 | 8 | 13 | 9 | |
Total assets | Rs m | 6,152 | 6,635 | 8,581 | 10,701 | 11,105 | |
Interest coverage | x | 14.8 | 20.7 | 56.1 | 53.2 | 29.1 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.2 | 1.3 | 1.4 | 1.4 | 1.3 | |
Return on assets | % | 5.0 | 5.4 | 11.5 | 9.7 | 3.7 | |
Return on equity | % | 11.4 | 11.8 | 25.5 | 18.4 | 5.1 | |
Return on capital | % | 12.3 | 14.4 | 26.3 | 23.3 | 7.7 | |
Exports to sales | % | 38.6 | 39.9 | 39.9 | 35.6 | 39.9 | |
Imports to sales | % | 34.8 | 30.8 | 35.5 | 37.5 | 30.5 | |
Exports (fob) | Rs m | 2,969 | 3,408 | 4,741 | 5,513 | 5,657 | |
Imports (cif) | Rs m | 2,671 | 2,628 | 4,216 | 5,794 | 4,324 | |
Fx inflow | Rs m | 2,969 | 3,408 | 4,741 | 5,513 | 5,657 | |
Fx outflow | Rs m | 2,739 | 2,701 | 4,304 | 5,906 | 4,444 | |
Net fx | Rs m | 230 | 707 | 437 | -392 | 1,213 |
MOREPEN LABS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 174 | 110 | 508 | -602 | -912 | |
From Investments | Rs m | -131 | -125 | -704 | -317 | -465 | |
From Financial Activity | Rs m | -4 | 55 | 473 | 663 | 1,435 | |
Net Cashflow | Rs m | 39 | 40 | 277 | -256 | 59 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Sushil Suri | COMP SEC: Vipul Kumar Srivastava | YEAR OF INC: 1984 | BSE CODE: 500288 | FV (Rs): 2 | DIV YIELD (%): - |
Read: MOREPEN LABS 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare MOREPEN LABS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.